TY - JOUR
T1 - The diagnostic accuracy of 18F-Fluorodeoxyglucose PET/CT in patients with gynecological malignancies
AU - Grisaru, Dan
AU - Almog, Benny
AU - Levine, Charles
AU - Metser, Ur
AU - Fishman, Ami
AU - Lerman, Hedva
AU - Lessing, Joseph B.
AU - Even-Sapir, Einat
PY - 2004/9
Y1 - 2004/9
N2 - Objective. To evaluate the diagnostic accuracy of integrated positron emission tomography/computerized tomography (PET/CT) in patients with gynecological cancer. Methods. Fifty-three consecutive patients with gynecologic malignancies were included. The patients were referred to our tertiary center to undergo a PET/CT scan. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of PET/CT were compared with the conventional imaging assessments [CT, magnetic resonance imaging (MRI) and ultrasonography (US)]. Results. All tested values were higher for PET/CT than those for the conventional modalities: sensitivity 0.97 vs. 0.40, specificity 0.94 vs. 0.65, PPV 0.97 vs. 0.70, and NPV 0.94 vs. 0.34, respectively. Conclusion. PET/CT is a reliable modality for assessing the extent of disease in patients with gynecologic malignancy.
AB - Objective. To evaluate the diagnostic accuracy of integrated positron emission tomography/computerized tomography (PET/CT) in patients with gynecological cancer. Methods. Fifty-three consecutive patients with gynecologic malignancies were included. The patients were referred to our tertiary center to undergo a PET/CT scan. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of PET/CT were compared with the conventional imaging assessments [CT, magnetic resonance imaging (MRI) and ultrasonography (US)]. Results. All tested values were higher for PET/CT than those for the conventional modalities: sensitivity 0.97 vs. 0.40, specificity 0.94 vs. 0.65, PPV 0.97 vs. 0.70, and NPV 0.94 vs. 0.34, respectively. Conclusion. PET/CT is a reliable modality for assessing the extent of disease in patients with gynecologic malignancy.
KW - Follow-up
KW - Positron emission tomography/computerized tomography
KW - Staging
UR - http://www.scopus.com/inward/record.url?scp=4444330328&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2004.05.053
DO - 10.1016/j.ygyno.2004.05.053
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:4444330328
SN - 0090-8258
VL - 94
SP - 680
EP - 684
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 3
ER -
